Electromed (NYSE:ELMD) Receives New Coverage from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Electromed (NYSE:ELMDGet Rating) in a research report issued to clients and investors on Thursday. The brokerage set a “strong-buy” rating on the stock.

Shares of ELMD stock opened at $12.59 on Thursday. Electromed has a 52-week low of $8.98 and a 52-week high of $13.85. The stock has a market cap of $107.43 million, a price-to-earnings ratio of 57.23 and a beta of 0.57. The business has a fifty day simple moving average of $12.50.

Electromed (NYSE:ELMDGet Rating) last released its quarterly earnings data on Tuesday, February 8th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.07 by $0.03. Electromed had a net margin of 4.94% and a return on equity of 5.77%. The business had revenue of $10.25 million during the quarter.

Electromed Company Profile (Get Rating)

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function.

Further Reading

Receive News & Ratings for Electromed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed and related companies with MarketBeat.com's FREE daily email newsletter.